SLC6A3 and neoplasm: Specifically, the expression levels of SLC6A3, MITD1, and PDHA1 exhibited an increasing trend with tumor pathological stage, whereas CCS, LIPT2, PDHB, and PDHA1 displayed a decreasing trend in response to radiation therapy.